Inspira Technologies Reports Positive Results from Clinical Study of HYLA Blood Sensor

Shots:

• The clinical study of AI-powered clip-on HYLA blood sensor (n=6) showed 96% accuracy vs. traditional blood test analyzers in open-heart surgery pts. The study was also used to test indicator for identifying oxygen deficiencies with 92.3% accuracy
• The study was conducted at Sheba Hospital, and Inspira plans to gather more patient data to enhance the system’s AI for early detection diagnostics
• Inspira expects new results to support FDA submission in H2’25 and aims to deploy the INSPIRA ART technology in US hospitals for data collection, data validation and post-market validation

Ref: PR Newswire | Image: Inspira Technologies

Related News:- Daiichi Sankyo Reports Interim Data of P-III (DESTINY-Gastric04) Study Evaluating Enhertu in HER2+ Metastatic Gastric Cancer Patients

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com